Page 40 - ILAE_Lectures_2015

63. Blanc F, Martinian L, Liagkouras I, Catarino C, Sisodiya SM, Thom M. Investigation of widespread neocortical
pathology associated with hippocampal sclerosis in epilepsy: a postmortem study. Epilepsia 2011;52:10-21.

64. Deasy NP, Jarosz JM, Elwes RC, Polkey CE, Cox TC. Thalamic changes with mesial temporal sclerosis: MRI.
Neuroradiology 2000;42:346-351.

65. Margerison JH, Corsellis JA. Epilepsy and the temporal lobes. A clinical, electroencephalographic and
neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. Brain 1966;89:499-
530.

66. Bertram EH, Zhang D, Williamson JM. Multiple roles of midline dorsal thalamic nuclei in induction and spread of
limbic seizures. Epilepsia 2008;49:256-268.

67. Sinjab B, Martinian L, Sisodiya SM, Thom M. Regional thalamic neuropathology in patients with hippocampal
sclerosis and epilepsy: a postmortem study. Epilepsia 2013;54(12):2125-2133.

68. Hagemann G, Lemieux L, Free SL, et al. Cerebellar volumes in newly diagnosed and chronic epilepsy. J Neurol
2002;249:1651-1658.

69. Hermann BP, Bayless K, Hansen R, Parrish J, Seidenberg M. Cerebellar atrophy in temporal lobe epilepsy. Epilepsy
Behav 2005;7:279-287.

70. Crooks R, Mitchell T, Thom M. Patterns of cerebellar atrophy in patients with chronic epilepsy: a quantitative
neuropathological study. Epilepsy Res 2000;41:63-73.

71. Teixeira RA, Li LM, Santos SL, Zanardi VA, Guerreiro CA, Cendes F. Crossed cerebellar atrophy in patients with
precocious destructive brain insults. Arch Neurol 2002;59:843-847.

72. Ohmori H, Ogura H, Yasuda M, et al. Developmental neurotoxicity of phenytoin on granule cells and Purkinje cells in
mouse cerebellum. J Neurochem 1999;72:1497-1506.

73. Tauer U, Knoth R, Volk B. Phenytoin alters Purkinje cell axon morphology and targeting in vitro. Acta Neuropathol
(Berl) 1998;95:583-591.

74. Hermann B, Seidenberg M, Sears L, et al. Cerebellar atrophy in temporal lobe epilepsy affects procedural memory.
Neurology 2004;63:2129-2131.

75. Sandok EK, O'Brien TJ, Jack CR, So EL. Significance of cerebellar atrophy in intractable temporal lobe epilepsy: a
quantitative MRI study. Epilepsia 2000;41:1315-1320.

76. Specht U, May T, Schulz R, et al. Cerebellar atrophy and prognosis after temporal lobe resection. J Neurol Neurosurg
Psychiatry 1997;62:501-506.

77. Palmini A, Najm I, Avanzini G, et al. Terminology and classification of the cortical dysplasias. Neurology 2004;62:S2-
8.

78. Blumcke I, Thom M, Aronica E, et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus
classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 2011;52:158-
174.

79. Fauser S, Schulze-Bonhage A, Honegger J, et al. Focal cortical dysplasias: surgical outcome in 67 patients in relation
to histological subtypes and dual pathology. Brain 2004;127:2406-2418.

80. Hildebrandt M, Pieper T, Winkler P, Kolodziejczyk D, Holthausen H, Blumcke I. Neuropathological spectrum of
cortical dysplasia in children with severe focal epilepsies. Acta Neuropathol (Berl) 2005;110:1-11.

81. Cepeda C, Hurst RS, Flores-Hernandez J, et al. Morphological and electrophysiological characterization of abnormal
cell types in pediatric cortical dysplasia. J Neurosci Res 2003;72:472-486.

82. Blumcke I, Lobach M, Wolf HK, Wiestler OD. Evidence for developmental precursor lesions in epilepsy-associated
glioneuronal tumors. Microsc Res Tech 1999;46:53-58.

83. Andre VM, Wu N, Yamazaki I, et al. Cytomegalic interneurons: a new abnormal cell type in severe pediatric cortical
dysplasia. J Neuropathol Exp Neurol 2007;66:491-504.

84. Englund C, Folkerth RD, Born D, Lacy JM, Hevner RF. Aberrant neuronal-glial differentiation in Taylor-type focal
cortical dysplasia (type IIA/B). Acta Neuropathol (Berl) 2005;109:519-533.

85. Fauser S, Becker A, Schulze-Bonhage A, et al. CD34-immunoreactive balloon cells in cortical malformations. Acta
Neuropathol (Berl) 2004;108:272-278.

86. Ying Z, Gonzalez-Martinez J, Tilelli C, Bingaman W, Najm I. Expression of Neural Stem Cell Surface Marker CD133
in Balloon Cells of Human Focal Cortical Dysplasia. Epilepsia 2005;46:1716-1723.

87. Tassi L, Pasquier B, Minotti L, et al. Cortical dysplasia: electroclinical, imaging, and neuropathologic study of 13
patients. Epilepsia 2001;42:1112-1123.

88. Thom M, Martinian L, Sen A, et al. An investigation of the expression of G1-phase cell cycle proteins in focal cortical
dysplasia type IIB. J Neuropathol Exp Neurol 2007;66:1045-1055.

89. Yasin SA, Latak K, Becherini F, et al. Balloon cells in human cortical dysplasia and tuberous sclerosis: isolation of a
pathological progenitor-like cell. Acta Neuropathol 2010;120:85-96.

90. Baybis M, Yu J, Lee A, et al. mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann Neurol
2004;56(4):478-487.

91. Chen J, Tsai V, Parker WE, Aronica E, Baybis M, Crino PB. Detection of human papillomavirus in human focal cortical
dysplasia type IIB. Ann Neurol 2012;72:881-892.

92. Coras R, Korn K, Bien CG, et al., No evidence for human papillomavirus infection in focal cortical dysplasia IIb. Ann
Neurol 2015:77(2):312-319.

93. Baulac S, Ishida S, Marsan E, et al. Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations.
Ann Neurol 2015;77(4):675-683.